7,024 Shares in CME Group Inc. $CME Bought by Roberts Glore & Co. Inc. IL

Roberts Glore & Co. Inc. IL acquired a new position in shares of CME Group Inc. (NASDAQ:CME) in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 7,024 shares of the financial services provider’s stock, valued at approximately $1,551,000.

A number of other large investors have also recently bought and sold shares of the stock. Whipplewood Advisors LLC raised its position in shares of CME Group by 2,075.0% in the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock valued at $26,000 after buying an additional 83 shares during the last quarter. Elkhorn Partners Limited Partnership acquired a new stake in CME Group during the 4th quarter worth approximately $27,000. Hilton Head Capital Partners LLC acquired a new position in shares of CME Group during the fourth quarter worth about $28,000. Mowery & Schoenfeld Wealth Management LLC purchased a new position in CME Group in the 2nd quarter valued at about $28,000. Finally, Legacy Wealth Managment LLC ID increased its stake in shares of CME Group by 191.9% in the fourth quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock worth $29,000 after buying an additional 71 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Transactions at CME Group

In other CME Group news, Director William R. Shepard acquired 325 shares of the company’s stock in a transaction that occurred on Thursday, June 25th. The shares were acquired at an average price of $230.57 per share, with a total value of $74,935.25. Following the purchase, the director owned 260,442 shares of the company’s stock, valued at $60,050,111.94. This represents a 0.12% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

CME has been the topic of several analyst reports. Wall Street Zen lowered CME Group from a “sell” rating to a “strong sell” rating in a research report on Saturday, August 1st. JPMorgan Chase & Co. lifted their target price on CME Group from $249.00 to $250.00 and gave the stock an “underweight” rating in a report on Thursday, July 23rd. The Goldman Sachs Group reduced their target price on CME Group from $267.00 to $245.00 and set a “sell” rating for the company in a report on Tuesday, June 30th. Bank of America boosted their target price on CME Group from $226.00 to $230.00 and gave the company an “underperform” rating in a research note on Thursday, July 23rd. Finally, Deutsche Bank Aktiengesellschaft lowered CME Group from a “buy” rating to a “hold” rating and cut their target price for the company from $286.00 to $270.00 in a report on Wednesday, August 19th. Nine research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, CME Group presently has a consensus rating of “Hold” and an average price target of $288.56.

CME Group Price Performance

Shares of CME Group stock opened at $277.32 on Wednesday. CME Group Inc. has a twelve month low of $218.31 and a twelve month high of $329.16. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The firm’s 50-day simple moving average is $251.75 and its 200-day simple moving average is $279.35. The firm has a market cap of $99.72 billion, a P/E ratio of 23.52, a price-to-earnings-growth ratio of 3.32 and a beta of 0.23.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, beating analysts’ consensus estimates of $2.91 by $0.08. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The firm had revenue of $1.71 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same period in the previous year, the business earned $2.96 earnings per share. The company’s revenue for the quarter was up .8% compared to the same quarter last year. As a group, research analysts expect that CME Group Inc. will post 12.27 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be paid a $1.30 dividend. The ex-dividend date of this dividend is Wednesday, September 9th. This represents a $5.20 annualized dividend and a yield of 1.9%. CME Group’s dividend payout ratio is presently 44.11%.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.